---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285403232.md"
description: "Medicus Pharma shares are trading higher after the company announced results from pre-specified expanded Phase 2 SKNJCT-003 data analysis."
datetime: "2026-05-06T15:08:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285403232.md)
  - [en](https://longbridge.com/en/news/285403232.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285403232.md)
---

# 

Medicus Pharma shares are trading higher after the company announced results from pre-specified expanded Phase 2 SKNJCT-003 data analysis.

### Related Stocks

- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)
- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)

## Related News & Research

- [EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline](https://longbridge.com/en/news/282836614.md)
- [Medicus Pharma Upsizes ATM Program to $50 Million With Maxim Group and Yorkville Securities](https://longbridge.com/en/news/284057169.md)
- [VIRGINIA RETIREMENT SYSTEMS ET Al Increases Stock Holdings in BridgeBio Pharma, Inc. $BBIO](https://longbridge.com/en/news/286643939.md)
- [07:52 ETMS Pharma Announces Strategic Growth Investment from Olayan Financing Company](https://longbridge.com/en/news/286766008.md)
- [RBC Capital Sticks to Its Hold Rating for aTyr Pharma (ATYR)](https://longbridge.com/en/news/286843768.md)